20083 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients; Organic compounds, e.g. phospholipids, fats Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING INDIGO NATURALIS OR ITS MAIN ACTIVE INGREDIENT AND PREPARATION METHOD AND USE THEREOF
#2Powder Composition Based On Microparticles Embedding Nanoparticles For The Delivery Of Therapeutic/Diagnostic Compounds
#3AMORPHOUS SOLID FORM AND PHARMACEUTICAL COMPOSITIONS OF LENVATINIB BESYLATE
#4NEW PHARMACEUTICAL COMPOSITION FOR DRUG DELIVERY
#5COMPOSITIONS FOR ENHANCED MUCOSAL PENETRATION
#6MICRONISED ANTIBODIES AND METHOD FOR THEIR OBTAINMENT
#7FORMULATIONS OF TEGAVIVINT
#8COMPOSITIONS AND METHODS FOR MAKING AND USING STABILIZED ENVELOPED VIRUSES BY SPRAY-DRYING AND LYOPHILIZATION
#9GRANULES FOR SUSPENSION
#10ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT
#11INHALATION FORMULATION FOR TREATING IPF DISEASE AND PREPARATION METHOD THEREFOR
#12SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION OF SIVELESTAT OR SALT THEREOF AND PREPARATION METHOD THEREOF
#13MODIFIED RELEASE FORMULATIONS OF IBUDILAST
#14METHODS FOR TREATING LIVER DISEASE
#15PEPTIDE PARTICLES AND METHODS OF FORMATION
#16TALC-FREE ACTIVE INGREDIENT COATING
#17ANTI-GDF15 ANTIBODY AND A DOSAGE REGIMEN FOR THE TREATMENT OF CANCER
#18PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#19Cannabidiol Solid Dosage Forms
#20FORMULATIONS OF RADIPRODIL
#21METHODS FOR TREATING CANCER USING INHALED ANGIOGENESIS INHIBITOR
#22ALL NATURAL GRANULATE
#23ADVANTAGEOUS HUMAN DOSAGE REGIMENS FOR ADMINISTRATION OF INX-315
#24GEPOTIDACIN FORMULATION
#25BLEND COMPOSITIONS FOR ORAL ADMINISTRATION AS A RAPIDLY DISSOLVING POWDER AND/OR SUSPENSION
#26NANOZYME-LOADED NUCLEUS PULPOSUS MATRIX HYDROGEL MICROSPHERE
#27COMPOSITIONS FOR THE TREATMENT OF CFTR-MEDIATED DISEASES
#28AN ANTIBACTERIAL PARENTERAL FORMULATION AND METHODS THEREOF
#29METHOD FOR PRODUCING GRANULES CONTAINING A CORE PARTICLE, GRANULES CONTAINING A CORE PARTICLE, PHARMACEUTICAL COMPOSITION CONTAINING THE GRANULES CONTAINING THE CORE PARTICLE, AND PREPARATION CONTAINING THE PHARMACEUTICAL COMPOSITION
#30PHARMACEUTICAL COMPOSITIONS
#31ISOXAZOLINE AND MACROCYCLIC LACTONE MICROSPHERES
#32USE OF PROBIOTIC COMPOSITION IN PREPARATION OF FORMULATION FOR IMPROVING VAGINAL HEALTH
#33POWDER MIXTURE COMPRISING REPARIXIN
#34USE OF A SPRAY FREEZE-DRYING PROCESS FOR THE LYOPHILIZATION OF A mRNA-ENCAPSULATING LIPID NANOPARTICLES FORMULATION
#35SPRAY DRIED FORMULATION OF A CHOLERA TOXIN B SUBUNIT VARIANT
#36METHODS OF FORMING PARTICLES BY CONTINUOUS DROPLET FORMATION AND DEHYDRATION
#37AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF
#38COMBINATION OF SGLT2 INHIBITORS AND MINERALCORTICOID RECEPTOR MODULATORS FOR USE IN TREATMENT OF CARDIORENAL DISEASES
#39LUBRICANT
#40SOLID DISPERSIONS OF PSILOCYBIN
#41EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE AND AMITRIPTYLINE HYDROCHLORIDE
#42PHARMACEUTICAL COMPOSITIONS OF TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITOR AND METHODS FOR MAKING SAME
#43AMORPHOUS DOSAGE FORM CONTAINING EBSELEN
#44PHARMACEUTICAL COMPOSITION FOR DRY POWDER INHALATION AND PREPARATION METHOD THEREOF
#45PLANT-DERIVED COMPOSITION
#46PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#47PHARMACEUTICAL COMPOSITION OF NUCLEOSIDE-DERIVED COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
#48FLOWPACK WITH COMPOSITION FOR IMPROVED TASTE MASKING OF ACTIVES
#49COMPOSITIONS AND METHODS FOR TREATING POMPE DISEASE
#50CENTANAFADINE PHARMACEUTICAL FORMULATIONS, AND METHODS OF MAKING AND USING SAME
#51NUTRACEUTICAL PARTICLES
#52PHARMACEUTICAL COMPOSITIONS AND METHODS
#53INHIBITING G CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CREB) BINDING PROTEIN (CBP)
#54METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE
#55LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE
#56METHODS OF FORMING PARTICLES BY CONTINUOUS DROPLET FORMATION AND DEHYDRATION
#57METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS
#58Surfactant Formulations for Inhalation
#59ANTI-GDF15 ANTIBODY AND A DOSAGE REGIMEN FOR THE TREATMENT OF CANCER
#60BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#61PHARMACEUTICAL DRY POWDER INHALATION FORMULATION
#62Method Of Treating Major Depressive Disorder
#63PHARMACEUTICAL COMPOSITION
#64Pretomanid Compositions
#65NANO-IN-MICRO ENCAPSULATED siRNA DRY POWDER, METHOD FOR PRODUCING THE SAME AND USE OF A POWDER FORMULATION
#66PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
#67INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE
#68COMPOSITIONS FOR THE TREATMENT OF CFTR-MEDIATED DISEASES
#69DRY POWDER COMPOSITIONS COMPRISING EUKARYOTIC CELLS AND METHOD OF THEIR MANUFACTURE AND USE
#70Formulation of Meloxicam
#71HIGH DOSAGE INJECTABLE BEVACIZUMAB FORMULATIONS AND METHODS
#72SARS-COV-2 RNA VACCINE COMPOSITIONS AND METHODS OF USE
#73SYNERGIC AND STABLE PHARMACEUTICAL COMPOSITION OF AN NSAID AND AN OPIOID ANALGESIC FOR PAIN AND INFLAMMATION
#74METHOD AND COMPOSITION FOR TREATING PULMONARY FIBROSIS
#75TYK2 INHIBITOR FORMULATIONS AND METHODS OF MAKING THE SAME
#76STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ERDAFITINIB
#77PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF
#78COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC STROKE, CONTAINING SOBREROL AS ACTIVE INGREDIENT
#79PEPTIDE HAVING ANTIDIABETIC ACTIVITY, PEPTIDE COMPLEX, AND USE THEREOF
#80INHALATION COMPOSITE AND CARRIER BASED FORMULATION COMBINATION
#81PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITION
#82METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER LUNG DISORDERS
#83METHOD OF TREATING MAJOR DEPRESSIVE DISORDER
#84LYOPHILIZED MESENCHYMAL STEM CELL DERIVED SECRETOME AND USES THEREOF
#85CRYSTALLINE FREEBASE FORMS OF A BIPHENYL COMPOUND
#86Delayed-Release Granulates of Melatonin, Combinations Comprising Melatonin, Pharmaceutical Compositions and Dietary Supplements Containing Them, and Their Use in the Treatment of Insomnia and for the Reduction of the Time Required to Fall Asleep
#87Oral Powder Mixture With Small Sized Particles
#88IMPROVED MANUFACTURING PROCESS
#89LOW-SORBING GLYBURIDE KIT, FORMULATION AND METHODS
#90UROLITHIN COMBINATION
#91LYMPHATIC DELIVERY OF NANOPARTICLES TO TREAT NEURODEGENERATIVE, NEUROLOGICAL, AND EYE CONDITIONS
#92LYOPHILIZED FORMULATIONS OF TEGAVIVINT
#93BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
#94Pharmaceutical Composition for Dry Powder Inhalation and Preparation Method Thereof
#95LOW-DOSE, STABLE-RELEASE TRANSDERMAL PREPARATION AND PATCH, AND METHOD FOR THEIR PRODUCTION
#96PHARMACEUTICAL COMPOSITIONS
#97PHARMACEUTICAL COMPOSITION FOR DRY POWDER INHALATION AND PREPARATION METHOD THEREOF
#98DIRECTLY COMPRESSIBLE MANNITOL GRANULES
#99Pharmaceutical Composition for Dry Powder Inhalation and Preparation Method Thereof
#100PHARMACEUTICAL COMPOSITION FOR DRY POWDER INHALATION AND PREPARATION METHOD THEREOF
#101FORMULATIONS OF RADIPRODIL
#102REDUCED REBOUND EFFECTS IN SUBJECTS TREATED FOR OVERWEIGHT OR OBESITY
#103STABLE GABAPENTIN POWDER
#104NOVEL COMPOSITION COMPRISING N-ACETYLCYSTEINE FOR OVERCOMING THE ADVERSE EFFECTS OF A CHEMOTHERAPY
#105SOLID ORAL DOSAGE FORM COMPRISING ANTIBODIES FOR SUSTAINED RELEASE IN THE LOWER GASTROINTESTINAL TRACT
#106PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS
#107LYOPHILIZED FORMULATION COMPRISING A FUSION PROTEIN INCLUDING a-GALACTOSIDASE A
#108PHARMACEUTICAL COMPOSITIONS
#109Dry Powder Formulations of Thymic Stromal Lymphopoietin (TSLP)-Binding Antibodies and Methods of Use Thereof
#110PHARMACEUTICAL COMPOSITION COMPRISING GHB GASTRO-RETENTIVE RAFT FORMING SYSTEMS HAVING TRIGGER PULSE DRUG RELEASE
#111COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
#112CANNABIS COMPOSITIONS AND METHODS OF MAKING THE SAME
#113COMPOSITIONS CONTAINING FEXOFENADINE
#114FUNCTIONAL FOODS COMPRISING DIAMINE OXIDASE AND USES THEREOF
#115FUNCTIONAL FOODS COMPRISING DIAMINE OXIDASE AND USES THEREOF
#116FORMULA OF NEUREGULIN PREPARATION
#117FREEZE-DRIED ARIPIRAZOLE FORMULATION
#118FORMULATIONS OF KINASE INHIBITORS AND PROSTANOIDS
#119FORMULATIONS OF GUANYLATE CYCLSE C AGONISTS AND METHODS OF USE
#120SPRAY DRIED INHALABLE BIOTHERAPEUTICS FOR THE TREATMENT OF DISEASE
#121DRY POWDER FORMULATIONS OF NARROW SPECTRUM KINASE INHIBITORS
#122SYNTHESIS OF ESTER, CARBONATE, AND CARBAMATE-DERIVED NOVEL BIODEGRADABLE IONIZABLE LIPIDS FROM METHYL RICINOLEATE OR METHYL 12-HYDROXYSTEARATE AND ITS APPLICATIONS
#123PHARMACEUTICAL COMPOSITION COMPRISING TIGECYCLINE
#124PEPTIDE HAVING PHYSIOLOGICAL ACTIVITIES AND USE THEREOF
#125LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO
#126PHARMACEUTICAL COMPOSITION OF SEPIAPTERIN
#127SOLID PARTICLES
#128PHARMACEUTICAL COMPOSITIONS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE
#129MULTIPARTICULATE ALBACONAZOLE COMPOSITION
#130CENTANAFADINE PHARMACEUTICAL FORMULATIONS, AND METHODS OF MAKING AND USING SAME
#131INHALABLE OR INGESTIBLE LACTIC ACID COMPOSITIONS FOR THE TREATMENT OF CHRONIC LUNG DISEASE
#132DIRECT TABLETING AUXILIARY COMPOSITION
#133Mouthwash For Oral Care Benefits
#134BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE
#135Reconstitutable, Single Use Antidiabetic Compositions
#136HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS
#137CONJUGATE PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF
#138CELL-DERIVED VESICLE RICH IN PROTEIN HOMEOSTASIS REGULATORS AND METHOD OF PREPARING SAME
#139MIXTURE OF AT LEAST ONE BACTERIOPHAGE AND OF AT LEAST ONE YEAST AND METHOD FOR DRYING SAME
#1405-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations
#141PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATION THEREOF, AND METHODS OF MAKING AND USING SAME
#142PHARMACEUTICAL FORMULATION
#143ORAL DOSAGE FORM CONTAINING ONCOLOGICAL ACTIVE INGREDIENT
#144MARIBAVIR COMPOSITIONS AND USES THEREOF
#145Pharmaceutical Composition for Dry Powder Inhalation and Preparation Method Thereof
#146PIMOBENDAN FORMULATION AND METHOD OF USE THEREOF
#147Compositions Comprising Guaifenesin and Eriodictyol
#148VIRUS
#149LYOPHILIZED FORMULATION SOLUTION AND LYOPHILIZED FORMULATION, AND METHOD AND USE THEREOF
#150FORMULATION WITH IMPROVED BIOAVAILABILITY
#151FIBRINOGEN COMPOSITIONS AND METHODS OF PREPARATION
#152COMPOSITIONS AND METHODS FOR TRANSPLANTATION OF COLON MICROBIOTA
#153Lyophilized Vortioxetine Pamoate Powder for Injection and Preparation Method Therefor
#154PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORS
#155EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE AND AMITRIPTYLINE HYDROCHLORIDE
#156INTRANASAL FORMULATIONS AND DELIVERY OF SOMATOSTATIN MIMETICS AND USES THEREOF
#157MEDICAL COUNTER MEASURES INCLUDING DRY POWDER FORMULATIONS AND ASSOCIATED METHODS
#158BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
#159STABLE SEMI-SOLID CHEWABLE GEL COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
#160BLEND COMPOSITIONS FOR ORAL ADMINISTRATION AS A RAPIDLY DISSOLVING POWDER AND/OR SUSPENSION
#161NEW BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM
#162COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF
#163FORMULATIONS OF TEGAVIVINT
#164BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF
#165SARS-CoV-2 RNA vaccine compositions and methods of use
#166PARTICLES, AQUEOUS DISPERSIONS, AND COMPOSITIONS HAVING HIGH LIPOPHILIC COMPONENT CONCENTRATIONS AND HIGH LIPOPHILIC COMPONENT TO SURFACTANT RATIOS
#167Inhalable Pharmaceutical Formulations
#168SOLID DOSAGE FORM HAVING EXCELLENT STABILITY
#169DISPIROPYRROLIDINE DERIVATIVES
#170Microencapsulation of Active Agents
#171SOLID COMPOSITION, FREEZE-DRYING METHOD AND GLASS VIAL
#172TRADITIONAL CHINESE MEDICINE COMPOSITION FOR INFECTIOUS DISEASE RECOVERY AND USE THEREOF
#173ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT
#174COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE MULTI-TARGETED ANTIGENS
#175METHOD FOR PREPARING CO-PROCESSED EXCIPIENT GRANULES
#17613C METHACETIN GRANULE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#177COMPOSITION AND PREPARATION METHOD THEREFOR
#178POLYMER PROTEIN MICROPARTICLES
#179Pharmaceutical Composition
#180AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF
#181KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS
#182INHALABLE DRY POWDER FORMULATIONS COMPRISING ANGIOGENESIS INHIBITORS
#183COMPOSITIONS AND METHODS FOR HARDENING
#184METHODS AND SYSTEMS FOR SPRAY DRYING TEMPERATURE SENSITIVE PRODUCTS
#185MPLA COMPOSITIONS AND METHODS OF USE
#186Mutant KRAS-Targeting Peptide and Use Thereof
#187COATED FAMOTIDINE PARTICLE
#188Centanafadine pharmaceutical formulations, and methods of making and using same
#189Pharmaceutical composition and administrations thereof
#190INHIBITING CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CREB) BINDING PROTEIN (CBP)
#191Agent for Adjusting Hardness of Lens of Eye
#192Compositions, methods and uses for thermally stable multi-targeted antigens
#193Composition for preventing hair loss or promoting hair growth comprising milk thistle flower extract as an active ingredient
#194PHARMACEUTICAL COMPOSITION OF MULTI-TARGET PROTEIN KINASE INHIBITORS, AND USE THEREOF
#195DEVICE AND METHOD FOR FORMING SPHERICAL PARTICLE CLUSTERS WITH ULTRAFINE POWDERS
#196Method Of Treating Major Depressive Disorder
#197METHOD FOR PREPARING PROTEIN MICROBEADS FOR IMPROVING STABILITY OF PROTEIN PREPARATION
#198Method Of Treating Major Depressive Disorder
#199Method of treating major depressive disorder
#200Lyophilized formulations of tegavivint
#201ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING PARTICULATE FORMULATION COMPRISING COMPOSITION
#202READILY DISPERSIBLE SHELF-STABLE MICROBIAL GRANULES
#203SILICA WITH ULTRA-FAST DISSOLUTION PROPERTIES
#204Respirable Polynucleotide Powder Formulations for Inhalation
#205Compositions and methods for treatment
#206IMMUNO-POTENTIATING ENZYMATIC EXTRACT OF DEER ANTLER THAT EXCELLENTLY ENHANCES ACTIVITY OF IMMUNE CELL INCLUDING NK CELL
#207Method and Composition for Treating Pulmonary Fibrosis
#208ANTI-GDF15 ANTIBODY AND A DOSAGE REGIMEN FOR THE TREATMENT OF CANCER
#209METHOD FOR PREPARING GYNOSTEMMA PENTAPHYLLUM LEAF EXTRACT AND GYNOSTEMMA PENTAPHYLLUM LEAF EXTRACT PREPARED THEREBY
#210FREEZE-DRIED ARIPIPRAZOLE FORMULATION
#211POWDER MIXING DEVICE, AND USES THEREOF
#212PROCESSES FOR MAKING AND USING A MESENCHYMAL STEM CELL DERIVED SECRETOME
#213DIHYDROERGOTAMINE DRY POWDER FORMULATIONS AND METHODS OF USE
#214NEW PHARMACEUTICAL COMPOSITION FOR DRUG DELIVERY
#215TABLETTABLE FORMULATION OF LUTEIN AND/OR ZEAXANTHIN
#216COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#217CAROTENOID PREPARATIONS, PREPARATION METHODS, AND APPLICATION THEREOF
#218STABILIZATION OF CANNABINOIDS WITHIN SOLID DOSAGE FORMS
#219Novel Formulation of Meloxicam
#220ENHANCED FORMULATION STABILIZATION AND IMPROVED LYOPHILIZATION PROCESSES
#221Cannabis compositions and methods of making the same
#222TREATMENT OR PREVENTION OF A DISEASE OR DISORDER
#223PHARMACEUTICALLY ACTIVE COMPOUND FORMULATIONS
#224PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES ASSOCIATED WITH VOLTAGE-GATED SODIUM CHANNELS
#225Methods for treating an ocular condition with cellular fibronectin compositions
#226Pharmaceutical formulation
#227METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES
#228MINIMIZING AGGLOMERATION OF DRUG PARTICLE COATING MATERIAL DURING STORAGE TO STABILIZE DISINTEGRATION TIMES OF PHARMACEUTICAL PRODUCTS
#229POWDER COMPOSITION BASED ON MICROPARTICLES EMBEDDING NANOPARTICLES FOR THE DELIVERY OF THERAPEUTIC/DIAGNOSTIC COMPOUNDS
#230Granular Pharmaceutical Composition
#231OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS
#232COMPOSITION FOR RELIEVING WOMAN MENOPAUSAL SYMPTOM COMPRISING A MIXED EXTRACT OF HOP AND CITRUS PEEL AND METHOD FOR TREATING OR ALLEVIATING MENOPAUSAL SYMPTOM USING THE SAME
#233COMPOSITION FOR RELIEVING CARDIOVASCULAR DISEASES OR OSTEOPOROSIS COMPRISING A MIXED EXTRACT OF HOP AND CYNANCHUM WILFORDII AND METHOD FOR TREATING OR ALLEVIATING CARDIOVASCULAR DISEASES OR OSTEOPOROSIS USING THE SAME
#234CRYSTAL FORM OF COMPOUND AND FUMARIC ACID, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING CORONAVIRUS-INDUCED DISEASES
#235MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE
#236HYDROXYPROPYL METHYL CELLULOSE DERIVATIVES TO STABILIZE POLYPEPTIDES
#237BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
#238INTRANASAL DELIVERY OF OLANZAPINE BY PRECISION OLFACTORY DEVICE
#239PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#240Rapamycin for the treatment of lymphangioleiomyomatosis
#241Pharmaceutical formulations
#242SPRAY DRIED LOW HYGROSCOPICITY ACTIVE POWDER COMPOSITIONS
#243Centanafadine pharmaceutical formulations, and methods of making and using same
#244MODIFIED ADENOSINE NUCLEOSIDE FOR USE IN THE TREATMENT OF VIRAL INFECTIONS
#245BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
#246Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#247THERAPEUTIC AGENT NANOPARTICLES AND METHODS OF PREPARATION
#248LOW HYGROSCOPICITY ACTIVE POWDER COMPOSITIONS
#249Crystalline freebase forms of a biphenyl compound
#250RESPIRATORY TRACT DELIVERY OF LEVODOPA AND DOPA DECARBOXYLASE INHIBITOR FOR TREATMENT OF PARKINSON'S DISEASE
#251FREEZE DRIED LOW HYGROSCOPICITY ACTIVE POWDER COMPOSITIONS
#252Lyophilized Formulations of AAV Drug Products
#253MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
#254Orodispersible dosage unit containing an estetrol component
#255FORMULATIONS OF 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF
#256DRY POWDER FORMULATIONS FOR INHALATION
#257Amorphous kinase inhibitor formulations and methods of use thereof
#258PHARMACEUTICAL COMPOSITIONS FOR IMPROVED DELIVERY OF THERAPEUTIC LIPOPHILIC ACTIVES
#259Inhalable formulation of fluticasone propionate and albuterol sulfate
#260INHALABLE RAPAMYCIN FORMULATION FOR THE TREATMENT OF PULMONARY HYPERTENSION
#261OSMOTIC DRUG DELIVERY SYSTEM
#262COMPOSITION AND MEDICAMENT OF PALBOCICLIB ISETHIONATE
#263PULMONARY FORMULATION COMPRISING CANNABINOIDS
#264IMPLANTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#265Method of treating major depressive disorder
#266ANATABINE POWDER COMPOSITIONS
#267INHALABLE FORMULATION
#268Blend compositions for oral administration as a rapidly dissolving powder and/or suspension
#269Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
#270EFFICIENT AQUEOUS ENCAPSULATION AND CONTROLLED RELEASE OF BIOACTIVE AGENTS
#271Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereof
#272Medical counter measures including dry powder formulations and associated methods
#273Formulations of tegavivint
#274INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES
#275METHODS OF FORMING PARTICLES BY CONTINUOUS DROPLET FORMATION AND DEHYDRATION
#276PROCESS OF MAKING IVABRADINE HYDROCHLORIDE DRUG PRODUCT
#277INHALABLE LACTOSE CONTAINING COMPOSITION
#278COMPOSITIONS AND METHODS FOR TRANSPLANTATION OF COLON MICROBIOTA
#279EXTENDED RELEASE LIQUID COMPOSITIONS OF GUAIFENESIN
#280PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ALOPECIA INCLUDING DECURSIN
#281PHARMACEUTICAL COMPOSITION OF LIPID NANOPARTICLE FOR DELIVERING NUCLEIC ACID DRUG CONTAINING TREHALOSE DERIVATIVE AND NOVEL STRUCTURE-MAINTAINING LIPID COMPOUND
#282BENZIMIDAZOLONE-BASED CINNAMAMIDE DERIVATIVE AS TRPV1 ANTAGONIST AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF PAIN CONTAINING SAME AS ACTIVE INGREDIENT
#283Compounds to Modulate Intestinal Absorption of Nutrients
#284NANOCRYSTAL MICROPARTICLES OF POORLY SOLUBLE DRUGS AND METHODS OF PRODUCTION AND USE THEREOF
#285NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#286Method for the Production of Commercial Nanoparticle and Microparticle Powders
#287Granular Pharmaceutical Composition
#288MONOCLONAL ANTIBODY DRY POWDERS
#289SOFT CHEWABLE FORMED BODY FOR THE ADMINISTRATION TO ANIMALS
#290PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NK/T-CELLLYMPHOMA OR NK-CELL LEUKEMIA, COMPRISING PHOSPHODIESTERASE TYPE 5 INHIBITOR
#291TREATMENT WITH POWDERED INTRANASAL EPINEPHRINE
#292Centanafadine pharmaceutical formulations, and methods of making and using same
#293Process for mesalazine solid formulations
#294PEPTIDE PARTICLES AND METHODS OF FORMATION
#295Composition for ameliorating psoriasis comprising cimicifugolide a as active ingredient
#296PROCESS FOR PREPARING SOLID FORMULATIONS COMPRISING A HYDROPHOBIC COMPOUND DISPERSIBLE IN A COLD LIQUID AND RELATIVE SOLID FORMULATIONS
#297Use of sodium dichloroisocyanurate (NaDCC) and a pharmaceutical formulation prepared therefrom
#298EDIBLE COMPOSITION FOR ALLEVIATING VISUAL FATIGUE
#299Methods for making compositions for pulmonary administration
#300WATER-DISPERSIBLE DRY POWDER FORMULATION AND PRODUCTION METHOD THEREOF